Industry News
Phosphagenics forms horse supplement JV
Phosphagenics (ASX:POH) has formed a joint venture with a subsidiary of Equine Nutrition Australia to market a line of horse supplements using its TPM delivery technology. [ + ]
Octa Phillip loses fight for Bioxyne
Shareholders in Bioxyne (ASX:BXN) resisted a call by investor group Octa Phillip to remove several directors and cease development of HI 164, instead voting to remove Octa's own MD from the board. [ + ]
Starpharma technology gives glyphosate a boost
Starpharma (ASX:SPL) said agrochemicals produced using its dendrimer program were more effective and rain-resistant than the original formulas during laboratory trials. [ + ]
GI Dynamics to start pivotal US trial of EndoBarrier
GI Dynamics (ASX:GID) has got the all-clear from the FDA to commence a 25-site pivotal trial of EndoBarrier in type 2 diabetes in the US. [ + ]
Green chemistry helps promote sustainable manufacturing
Greener manufacturing in the chemical, pharmaceutical and food industries has received a boost following the establishment of the $24.9 million Victorian Centre for Sustainable Chemical Manufacturing (VCSCM). [ + ]
CSIRO leads additive manufacturing charge with new titanium facility
CSIRO has announced the opening of a new titanium additive manufacturing facility that will be used for developing advanced titanium parts for aerospace, medical, automotive and manufacturing applications. [ + ]
Phosphagenics licenses TPM to Indian pharma
India's Agila Specialties has arranged to license Phosphagenics' (ASX:POH) TPM drug delivery platform, and use it to create an injectable antibiotic product. [ + ]
AusBiotech 2012 special feature: Big deals
Be it through major licensing or development deals, domestic and international expansion, mergers and spin-offs or potentially game-changing research, biotechnology companies across Australia have been making waves in recent months. [ + ]
AusFoodTech Symposium 2012 to feature Dr Andrew Powell
The second AusFoodtech symposium, to be held on Friday in Melbourne, will feature keynote speaker, Dr Andrew Powell, Chief Executive Officer of Asia BioBusiness. [ + ]
Benitec completes Tacere acquisition
Benitec Biopharma (ASX:BLT) has completed the acquisition of US-based RNA interference therapeutics discovery company Tacere Therapeutics. [ + ]
High-performance computing transforms research
New super-fast, high-performance computing (HPC) being installed by La Trobe University, RMIT University and Victorian Partnership for Advanced Computing (VPAC) will revolutionise the computational modelling and simulation technologies available to researchers. [ + ]
Melbourne Uni cuts deal with Janssen-Cilag to research respiratory infection drug
The University of Melbourne and Janssen-Cilag have signed a collaboration agreement covering research into drug candidates for acute respiratory infections. [ + ]
Starpharma technology improves anti-cancer drug 40-fold
Animal trials of Starpharma's (ASX:SPL) dendrimer-docetaxel chemotherapy product show the formulation is potentially far more effective at targeting tumours than the conventional formula. [ + ]
Next generation sequencing reveals pancreatic cancer’s secrets
A new genomic study shows pancreatic cancer is not just a single cancer but has many variations, requiring potentially many different treatments. [ + ]
AusBiotech 2012 special feature: Found in translation
Here are five ways that are currently being discussed that could transform the commercialisation of medical research in Australia. [ + ]
